Plant-produced insulin trials begin in UK | Checkbiotech

Home | Contact Us | Partnership | Site Map

left shadow

Checkbiotech - for emerging fields of science

NEWSLETTERS SUBMIT CONTENT

Checkbiotech Home

Sign In | Register

bottom shadow


	View Edit Domain: GreenBio Title: * Body: Canadian biotech firm SemBioSys has begun UK-based phase I/II trials of its insulin which it produces from genetically-engineered safflower plants. <br /> <br /> It represents the first time that the plant-produced insulin has been used on humans with up to 30 healthy volunteers taking part. The trial will compare the efficacy of SemBioSys’ insulin with two commercially-available forms of insulin. SemBioSys says its version is physically, structurally and functionally indistinguishable from ordinary pharmaceutical-grade insulin. <br /> <br /> "This sophisticated trial is designed to show bioequivalence with respect to insulin concentrations as well as insulin action on blood glucose,” says SemBioSys acting chief medical officer Bruce Given.<br /> <br /> The results of the trial are expected in the first half of 2009. <br /> <br /> SemBioSys announced on 24 December 2008 that Mannkind Corporation has bought an option to licence rights for the plant-produced insulin for $2.5m. The deal was expected to close on 5 January 2009. The option period will end on 31 March 2009.<br /> <br /> Copyright 2009 Institution of Chemical Engineers<br /> Captcha: Please Enter Code : * Time Zone: * Select the time zone Vocabularies Newsletter: Domain: Show summary in full view Input format Filtered HTML Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically. Full HTML Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically. news_filter Web page addresses and e-mail addresses turn into links automatically. More information about formatting options			Related Articles Cotton stainer, future threat to Pakistan New study reignites debate over GMO safety Plant-produced monoclonal antibody enters Phase I GM crops by backdoor Scientists Refute Claim That Genetically Modified Corn Cause... Bt corn farms expanding Rothamsted Research submits application to ACRE for permissi... Potato trials and research provide grower information SemBioSys receives US$2.5 million from option agreement with... Scientists find genetic trick to make iron-rich rice Top GreenBio Articles

Home | Partnership | Contact Us | Site Map | News Site Map
© 2000-2012 Checkbiotech.org | Disclaimer